Ciprofloxacin Hydrochloride and Hydrocortisone Otic Suspension/Drops — FDA Drug Shortage

To Be Discontinued — Sandoz Inc.

The FDA lists a drug shortage record for Ciprofloxacin Hydrochloride and Hydrocortisone Otic Suspension/Drops from Sandoz Inc. with status To Be Discontinued. The shortage was first posted on Oct 30, 2026.

Shortage details

Status
To Be Discontinued
Company
Sandoz Inc.
Package NDC
66758-087-70
Presentation
Cipro, Otic Suspension/Drops, 0.2% base, 1% (NDC 66758-087-70)
Initial Posting
Oct 30, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.